GlaxoSmithKline starts final-stage tests on severe asthma drug – Fox News

GlaxoSmithKline starts final-stage tests on severe asthma drug
Fox News
Severe refractory asthma only affects around 4 percent of patients with the disease, so the drug may not become a major seller for GSK but could consolidate the group's strong grip on the market for lung drugs. Print; Email; Share; Comments; Recommend
GSK Begins Phase lll Program for Mepolizumab in Severe Refractory AsthmaFox Business
GSK starts final-stage tests on severe asthma drugWHTC

all 14 news articles »

View full post on asthma – Google News

GSK starts final-stage tests on severe asthma drug – Reuters

GSK starts final-stage tests on severe asthma drug
Reuters
Severe refractory asthma only affects around 4 percent of patients with the disease, so the drug may not become a major seller for GSK but could consolidate the group's strong grip on the market for lung drugs. (Reporting by Ben Hirschler). Health
GSK Begins Phase lll Program for Mepolizumab in Severe Refractory Asthma4-traders

all 5 news articles »

View full post on asthma – Google News

Many asthmatics do well on food-allergy tests, study finds – PhysOrg.com


The Times of Trenton – NJ.com

Many asthmatics do well on food-allergy tests, study finds
PhysOrg.com
(HealthDay) — People with asthma fare better on a type of food-allergy test called a "food challenge" than non-asthmatics, new research suggests. Food challenges involve people suspected of having a food allergy eating small amounts of the food orally
Treating symptoms of allergic rhinitis improved asthma outcomesPediatric SuperSite
Seasonal Allergies: Symptoms, Causes and CopingNewsolio
Heavy rains from summer, mild winter set stage for springtime attacks and The Times of Trenton – NJ.com

all 6 news articles »

View full post on asthma – Google News